NEWS FROM SWEDEN: First delivery of extemporaneous medicinal products manufactured using 3D technology
https://press.apl.se/posts/pressreleases/forsta-leveransen-av-extemporelakemedel-tillv
Success story, Joseph Shoyoye, One Pharmacy
Discover how Joseph Shoyoye of One Pharmacy leverages automation to enhance precision, consistency, and efficiency in modern pharmaceutical compounding.
Interview with Vanity Thomas, from The Woodlands Compounding Pharmacy
Discover why Vanity Thomas from The Woodlands Compounding Pharmacy prefers the CurifyLabs Compounding System Solution in our latest interview.
Success story, Ryan Wooden, Collierville Compounding Pharmacy
Automated technology from CurifyLabs enhances dosing precision and consistency at Collierville Compounding Pharmacy, revolutionizing patient-centric therapies and compounding practices.
Revolutionizing pharmaceutical treatment with the help of new technologies - case iGalenici in Italy
Revolutionizing pharmaceutical treatment with the help of new technologies - case iGalenici in Italy
Live From Training the Helios Erfurt Pharmacy Team!
3D printed medicines Helios Erfurt Pharmacy automated compounding technology non-sterile
Interview with Dr. Florian Immekus, Pharmacy Director, Mühlenkreiskliniken, Germany
Interview with Dr. Florian Immekus, Pharmacy Director, Mühlenkreiskliniken, Minden, Germany
Jana Lass, Tartu Hospital Pharmacy
Insights from Jana Lass at Tartu Hospital on integrating CurifyLabs' 3D-printing technology for personalized medicine, addressing stakeholder feedback and future possibilities in hospital settings.
Dr. Marija Tubic Grozdanis & Prof. Dr. Alexandra Russo, University Medical Center Mainz
Exploring the role of personalized medicine in pediatric cancer treatment with insights from experts at the University Medical Center Mainz. Discover the future of tailored therapies for children.
Samuli Ojala, Vaasan Hietalahden Apteekki
Discover the importance of personalized medicine through compounding and how it benefits niche patient groups like pets, children, and the elderly.
Interview with Erik Haeffler, CEO, APL
Interview with Erik Haeffler on APL's role in developing personalized medicines for patients with unique needs using innovative CSS-technology.